article

• A comparison of pharmacokinetics software for therapeutic drug monitoring of piperacillin in patients with severe infections.  European Journal of Hospital Pharmacy.  :-. 2022-01-01
• Amikacin pharmacokinetics in elderly patients with severe infections.  European Journal of Pharmaceutical Sciences.  175:-. 2022-01-01
• Disease activity and therapeutic drug monitoring of polyglutamates of methotrexate after daily or weekly administration of low-dose methotrexate in patients recently diagnosed with rheumatoid arthritis.  Basic and Clinical Pharmacology and Toxicology.  130:644-654. 2022-01-01
• Simultaneous determination of four serotonin selective reuptake inhibitors by an UPLC MS-MS method with clinical application in therapeutic drug monitoring.  Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences.  1193:-. 2022-01-01
• Clinical utility of ABCB1 and ABCG2 genotyping for assessing the clinical and pathological response to FAC therapy in Mexican breast cancer patients.  Cancer Chemotherapy and Pharmacology.  87:843-853. 2021-01-01
• Factors associated with fluoxetine and norfluoxetine plasma concentrations and clinical response in Mexican patients with mental disorders.  Pharmacology Research and Perspectives.  9:-. 2021-01-01
• Methotrexate Triglutamate as a Determinant of Clinical Response in Mexican Patients With Rheumatoid Arthritis: Pharmacokinetics and Dose Recommendation.  Journal of Clinical Pharmacology.  61:1118-1130. 2021-01-01
• Optimizing Meropenem Therapy for Severe Nosocomial Infections in Neonates.  Journal of Pharmaceutical Sciences.  110:3520-3526. 2021-01-01
• Quantification of pyrazinamide, isoniazid, acetyl-isoniazid, and rifampicin by a high-performance liquid chromatography method in human plasma from patients with tuberculosis.  Journal of Separation Science.  44:521-529. 2021-01-01
• A population approach of rifampicin pharmacogenetics and pharmacokinetics in Mexican patients with tuberculosis.  Tuberculosis.  124:-. 2020-01-01
• Dosing Recommendations Based on Population Pharmacokinetics of Lamotrigine in Mexican Adult Patients With Epilepsy.  Journal of Pharmaceutical Sciences.  109:2902-2908. 2020-01-01
• Population Pharmacokinetics and Dosing Recommendations of Levetiracetam in Adult and Elderly Patients With Epilepsy.  Journal of Pharmaceutical Sciences.  109:2070-2078. 2020-01-01
• Population pharmacokinetics of amikacin administered once daily in patients with different renal functions.  Antimicrobial Agents and Chemotherapy.  64:-. 2020-01-01
• Population pharmacokinetics of isoniazid and dose recommendations in Mexican patients with tuberculosis.  International Journal of Clinical Pharmacy.  42:1217-1226. 2020-01-01
• Population pharmacokinetics of methotrexate in Mexican pediatric patients with acute lymphoblastic leukemia.  Cancer Chemotherapy and Pharmacology.  85:21-31. 2020-01-01
• Population pharmacokinetics of mycophenolic acid in adult kidney transplant patients under prednisone and tacrolimus regimen.  European Journal of Pharmaceutical Sciences.  150:-. 2020-01-01
• Anthropometric and Genetic Factors Associated with the Exposure of Rifampicin and Isoniazid in Mexican Patients with Tuberculosis.  Therapeutic Drug Monitoring.  41:648-656. 2019-01-01
• Determination of mycophenolic acid in human plasma by ultra-performance liquid chromatography–tandem mass spectrometry and its pharmacokinetic application in kidney transplant patients.  Biomedical Chromatography.  33:-. 2019-01-01
• Dosing recommendations based on population pharmacokinetics of tacrolimus in Mexican adult patients with kidney transplant.  Basic and Clinical Pharmacology and Toxicology.  124:303-311. 2019-01-01
• Arylamine N-acetyltransferase 1 in situ N-acetylation on CD3 peripheral blood mononuclear cells correlate with NATb mRNA and NAT1 haplotype.  Archives of Toxicology.  92:661-668. 2018-01-01
• Population pharmacokinetics of levetiracetam in neonates with seizures.  Journal of Clinical Pharmacy and Therapeutics.  43:422-429. 2018-01-01
• Analysis of transcription factors, microRNAs and cytokines involved in T lymphocyte differentiation in patients with tuberculosis after directly observed treatment short-course.  Tuberculosis.  105:1-8. 2017-01-01
• Influence of mechanical ventilation on the pharmacokinetics of vancomycin administered by continuous infusion in critically ill patients.  Antimicrobial Agents and Chemotherapy.  61:-. 2017-01-01
• Measurement of levofloxacin in human plasma samples for a reliable and accessible drug monitoring.  Clinical Biochemistry.  50:73-79. 2017-01-01
• Aluminum Contamination in Parenteral Nutrition Admixtures for Low-Birth-Weight Preterm Infants in Mexico.  Journal of Parenteral and Enteral Nutrition.  40:1014-1020. 2016-01-01
• Induction of transcription factors, miRNAs and cytokines involved in T lymphocyte differentiation in BCG-vaccinated subjects.  Molecular Immunology.  77:44-51. 2016-01-01
• Pharmacokinetics of vancomycin and dosing recommendations for trauma patients.  Journal of Antimicrobial Chemotherapy.  71:471-479. 2016-01-01
• Clinical pharmacokinetics of rifampin in patients with tuberculosis and type 2 diabetes mellitus: Association with biochemical and immunological parameters.  Antimicrobial Agents and Chemotherapy.  59:7707-7714. 2015-01-01
• Population pharmacokinetic analysis of Tacrolimus in adult Mexican patients with renal transplant.  Biomedical and Pharmacology Journal.  8:47-56. 2015-01-01
• Population pharmacokinetics of gentamicin and dosing optimization for infants.  Antimicrobial Agents and Chemotherapy.  59:482-489. 2015-01-01
• Expression of NAT2 in immune system cells and the relation of NAT2 gene polymorphisms in the anti-tuberculosis therapy in Mexican mestizo population.  Molecular Biology Reports.  41:7833-7843. 2014-01-01
• Limited sampling strategies to predict the area under the concentration-time curve for rifampicin.  Therapeutic Drug Monitoring.  36:746-751. 2014-01-01
• Pharmacokinetics of rifampicin in Mexican patients with tuberculosis and healthy volunteers.  Journal of Pharmacy and Pharmacology.  66:1421-1428. 2014-01-01
• Relative bioavailability of isoniazid in a fixed-Dose combination product in healthy Mexican subjects.  International Journal of Tuberculosis and Lung Disease.  18:49-54. 2014-01-01
• Population pharmacokinetics of rifampicin in Mexican patients with tuberculosis.  Journal of Clinical Pharmacy and Therapeutics.  38:56-61. 2013-01-01
• Relationship among changes in hematocrit, albumin and corticosteroid dose on the disposition of tacrolimus during the first six months following renal transplantation.  Proceedings of the Western Pharmacology Society.  54:29-31. 2011-01-01
• Relative bioavailability of rifampicin in a three-drug fixed-dose combination formulation.  International Journal of Tuberculosis and Lung Disease.  14:1454-1460. 2010-01-01
• Drug utilization review of tablets of clonazepam in external consult in a general hospital [Utilización de tabletas de clonazepam en la consulta externa de un hospital general].  Revista Mexicana de Ciencias Farmaceuticas.  40:19-25. 2009-01-01
• Evaluation of population pharmacokinetic models for amikacin dosage individualization in critically ill patients.  Journal of Pharmacy and Pharmacology.  61:759-766. 2009-01-01
• Population pharmacokinetics of carbamazepine in epileptic children [Farmacocinética poblacional de carbamazepina en niños epilépticos].  Revista Mexicana de Ciencias Farmaceuticas.  40:19-27. 2009-01-01
• Quantitative analysis of regulatory T cells in kidney graft recipients: A relationship with calcineurin inhibitor level.  Transplant Immunology.  21:43-49. 2009-01-01
• Population pharmacokinetics of cefepime in neonates with severe nosocomial infections.  Journal of Clinical Pharmacy and Therapeutics.  33:295-306. 2008-01-01
• Population pharmacokinetics of valproate in Mexican children with epilepsy.  Biopharmaceutics and Drug Disposition.  29:511-520. 2008-01-01
• Micromethod for the determination of cefepime by high performance liquid chromatography [Micrométodo para la determinación de cefepime en plasma mediante cromatografía de líquidos de alta resolución].  Revista Mexicana de Ciencias Farmaceuticas.  38:34-41. 2007-01-01
• Simultaneous HPLC determination of isoniazid and acetylisoniazid in plasma.  Acta Chromatographica.  110-118. 2007-01-01
• Population pharmacokinetics of carbamazepine in adults with epilepsy [Farmacocinética poblacional de carbamacepina en pacientes epilépticos adultos] 2005-01-01
• Occupational area: Important aspect in the curricular design for the pharmacy career (QFB) at UASLP [Mercado ocupacional: Un aspecto importante en la determinación curricular del Quimico farmacobiólogo en la Universidad Autonoma de San Luis potosi (UASLP)].  Revista Mexicana de Ciencias Farmaceuticas.  32:20-23. 2001-01-01
• Population pharmacokinetics of amikacin in patients with haematological malignancies.  Journal of Antimicrobial Chemotherapy.  44:235-242. 1999-01-01
• Influence of clinical diagnosis in the population pharmacokinetics of amikacin in intensive care unit patients.  Clinical Drug Investigation.  15:435-444. 1998-01-01
• Pharmacokinetics of amikacin in intensive care unit patients.  Journal of Clinical Pharmacy and Therapeutics.  21:417-421. 1996-01-01